Zio by iRhythm

Clinical trial: Zio by iRhythm significantly improves health outcomes for at-risk patients

Data published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events, furthering the case for cardiac screening.
AliveCor user

AliveCor’s KardiaMobile devices get an expanded range of ECG determinations

The company's device now detects six times as many cardiac conditions as any other personal ECG...
EchoGo Core on tablet

Ultromics, Mayo Clinic to use AI to improve diagnosis of heart failure

The team will use AI analysis of ultrasound heart scans to identify the markers of heart failure and develop an image analysis risk prediction model.
Bayer

Bayer, Sidekick to provide digital therapy program for PAD patients

Sidekick develops gamified digital therapeutic solutions and programs, designed to transform chronic disease management across multiple therapeutic areas.
Eko unveils second generation of its CORE smart stethoscope

Eko unveils the second generation of its CORE smart stethoscope

The redesigned Eko CORE boasts active noise cancellation, sleeker design, and powerful software to allow for more effective screening for heart disease.
iRhythm

iRhythm, Verily to develop health management solutions for Atrial Fibrillation patients

The two companies aim to collaborate on solutions providing early warnings, enabling the identification of patients that could otherwise go undiagnosed.
Omron Healthcare Product Family

Omron unveils a real blood-pressure smartwatch

The company has also unveiled the Omron Blood Pressure Monitor + EKG, the first single at-home device in the U.S. that measures blood pressure and EKG.
MyGeneRank app

Scripps’ ResearchKit-based study looks at how genetic risk influences heart health decisions

Called MyGeneRank, the app allows users with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.
Kardia Mobile with Phone

AliveCor, Mayo Clinic to use AI to help prevent sudden cardiac death

The two parties have teamed-up to develop tools for medical and non-medical personnel to easily screen for congenital long QT syndrome (LQTS) early.
AliveCor fingers Kardia - iPhone

AliveCor unveils AI-enabled, stroke-preventing platform for doctors, raises $30M

The platform is designed to help doctors monitor patients for the early detection of atrial fibrillation, which is the most common cardiac arrhythmia.